abstract |
The present invention relates to a novel method for producing a metabolite from atorvastatin using bacterial cytochrome P450 and a composition therefor, and more particularly to a method for producing a bacterial cytochrome P450 BM3 (CYP102A1), a mutant of CYP102A1 and a mutant of CYP102A1 The present invention relates to a composition for producing a 2-hydroxylated product or a 4-hydroxylated product from atorvastatin containing a chimera, a kit, and a production method thereof. |